Elanco’s IPO Would Free Eli Lilly to Focus on Pharmaceuticals

Elanco’s IPO Would Free Eli Lilly to Focus on Pharmaceuticals

Source: 
Xconomy
snippet: 

Elanco, the animal health business of Eli Lilly, has filed for an IPO, setting in motion the process of splitting from its parent company of more than 60 years.